Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 3,185 |
|
|||||
| News | - | ||||||
| Day High | 0.654701 | Low High |
|||||
| Day Low | 0.6361 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Lipella Pharmaceuticals Inc | LIPO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0067 | 1.03% | 0.654701 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.6412 | 0.6361 | 0.654701 | 0.654701 | 0.648 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 45 | 3,185 | US$ 0.6444928 | US$ 2,053 | - | 0.6054 - 2.71 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 15 | US$ 0.636 | USD |
Lipella Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.06M | 6.25M | - | 450k | -4.62M | -0.74 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Lipella Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LIPO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.61 | 0.679999 | 0.61 | 0.6490547 | 13,012 | 0.0447 | 7.33% |
| 1 Month | 0.7599 | 0.788 | 0.6054 | 0.7021648 | 33,040 | -0.1052 | -13.84% |
| 3 Months | 0.7543 | 0.89 | 0.6054 | 0.7216684 | 30,503 | -0.0996 | -13.20% |
| 6 Months | 1.04 | 1.30 | 0.6054 | 0.8183481 | 40,074 | -0.3853 | -37.05% |
| 1 Year | 1.93 | 2.71 | 0.6054 | 1.96 | 216,993 | -1.28 | -66.08% |
| 3 Years | 7.02 | 7.72 | 0.6054 | 2.52 | 316,880 | -6.37 | -90.67% |
| 5 Years | 7.02 | 7.72 | 0.6054 | 2.52 | 316,880 | -6.37 | -90.67% |
Lipella Pharmaceuticals Description
| Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania. |
